These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9057403)

  • 21. COACH syndrome: an unusual cause of neonatal cholestasis.
    Weiland MD; Nowicki MJ; Jones JK; Giles HW
    J Pediatr; 2011 May; 158(5):858-858.e1. PubMed ID: 21237470
    [No Abstract]   [Full Text] [Related]  

  • 22. Kabuki syndrome and neonatal cholestasis: report of a new case and review of the literature.
    Isidor B; Rio M; Mourier O; Habes D; Amiel J; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):261-4. PubMed ID: 17667726
    [No Abstract]   [Full Text] [Related]  

  • 23. Solid Liver Lesions in an Infant With Neonatal Cholestasis: Is it Always Malignant?
    Bariş Z; Börcek P; Haberal KM; Özçay F
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):626-628. PubMed ID: 28816798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance.
    Gerber MA; Orr W; Denk H; Schaffner F; Popper H
    Gastroenterology; 1973 Jan; 64(1):89-98. PubMed ID: 4119149
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).
    Ekema G; Falchetti D; Boroni G; Tanca AR; Altana C; Righetti L; Ridella M; Gambarotti M; Berchich L
    J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis and prevention of acute liver insufficiency in obstructive jaundice].
    Ivanov AIa; Susla PA; Usol'tseva GE
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):44-9. PubMed ID: 4432343
    [No Abstract]   [Full Text] [Related]  

  • 28. Referral Patterns and Factors Influencing Age at Admission of Infants with Cholestasis in India.
    Mathiyazhagan G; Jagadisan B
    Indian J Pediatr; 2017 Aug; 84(8):591-596. PubMed ID: 28397065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver biopsy in neonatal cholestasis: a review on statistical grounds.
    Zerbini MC; Gallucci SD; Maezono R; Ueno CM; Porta G; Maksoud JG; Gayotto LC
    Mod Pathol; 1997 Aug; 10(8):793-9. PubMed ID: 9267821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic cholestasis in a young man.
    Ludwig J; Rosen CB; Lindor KD; Helzberg JH; Watson KR
    Hepatology; 1994 Nov; 20(5):1351-5. PubMed ID: 7927271
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of liver insufficiency in obstructive jaundice].
    Krakovskiĭ AI; Magarill IuA; Piskunov VP
    Khirurgiia (Mosk); 1983 Jan; (1):31-6. PubMed ID: 6827789
    [No Abstract]   [Full Text] [Related]  

  • 32. Neonatal cholestasis syndrome: Indian scene.
    Yachha SK; Mohindra S
    Indian J Pediatr; 1999; 66(1 Suppl):S94-6. PubMed ID: 11132478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic clinical challenges and images in GI. Image 1. Mirizzi syndrome with white bile syndrome.
    Singh S; Tang SJ
    Gastroenterology; 2009 Jun; 136(7):e1-2. PubMed ID: 19427316
    [No Abstract]   [Full Text] [Related]  

  • 34. Interpretation of commonly employed tests of liver function and integrity.
    Tucker LE; Collins RH
    Mo Med; 1985 Dec; 82(12):751-5. PubMed ID: 4088184
    [No Abstract]   [Full Text] [Related]  

  • 35. Obstetric cholestasis. A mother's experience.
    Chambers J
    Pract Midwife; 2001 Apr; 4(4):18. PubMed ID: 12026608
    [No Abstract]   [Full Text] [Related]  

  • 36. [The lipoprotein X-test. Pointing out abnormal lipoprotein in cholestasis].
    Ritland S
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1155-6. PubMed ID: 4751603
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cholestasis and pregnancy: hepatopathies specific to pregnancy].
    Dorta G
    Arch Gynecol Obstet; 1994; 255 Suppl 2():S237-44. PubMed ID: 7847908
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cholestasis-induced liver injury: the role of S1PR2].
    Dissous L; Cesard E; Dance A; Tordjmann T
    Med Sci (Paris); 2017; 33(6-7):606-609. PubMed ID: 28990561
    [No Abstract]   [Full Text] [Related]  

  • 39. Acquired liver injury in the intensive care unit.
    Lescot T; Karvellas C; Beaussier M; Magder S
    Anesthesiology; 2012 Oct; 117(4):898-904. PubMed ID: 22854981
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.